Cite Filings / MAIA / 0001493152-25-026173

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

MAIA Biotechnology, Inc. Filed 2025-12-04 Acc 0001493152-25-026173

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-12-09 4 Director bought 13,740 shares at an average $1.20 ($16,441)
2025-12-04 4/A Chief Executive Officer bought 10,500 shares at $0.97 ($10,144)
2025-12-04 4/A Chief Executive Officer bought 72,000 shares at an average $1.11 ($79,849)
2025-12-04 SCHEDULE 13D/A Beneficial Ownership Report
2025-12-01 4 Chief Executive Officer bought 72,000 shares at an average $1.11 ($79,849)
2025-12-01 4 Director bought 38,145 shares at an average $1.10 ($41,846)
2025-12-01 4 Director bought 15,000 shares at $1.04 ($15,582)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…